Lipid nanoparticles (LNP’s) came to prominence for delivery of RNA with the success of the Moderna and Pfizer BioNTech COVID-19 vaccines. They are also used to deliver therapeutic treatments ...

We spoke to Örn Almarsson about the therapeutic potential of mRNA lipid nanoparticles and the techniques being used to ...

Lipid nanoparticles (LNP’s) came to prominence for delivery of RNA with the success of the Moderna and Pfizer BioNTech COVID-19 vaccines. They are also used to deliver therapeutic treatments including ...

Scientists have made a key breakthrough in treating respiratory diseases by developing a new drug delivery system that ...

biotechnology companies that produce RNA and mRNA medicines, respectively. More information: Zwitterionic Polymer-Functionalized Lipid Nanoparticles for the Nebulized Delivery of mRNA, Journal of ...

A University of Nottingham’s School of Pharmacy team has developed a cryogenic mass spectrometry approach to allow for the ...

The global lipid nanoparticles market is on the cusp of remarkable expansion, projected to grow at a CAGR of 14% through 2035, according to a recent industry analysis. Estimated to generate USD 1,144.

Inhalable nanovaccines offer needle-free, mucosal immunity against respiratory diseases like COVID-19, influenza, and TB.